Press Releases

GlobeNewswire, Inc.

— The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...

GlobeNewswire, Inc.

— The lowered pricing structure is now available for 798,86 DKK per bottle at pharmacies throughout Denmark AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...

GlobeNewswire, Inc.

— The lowered pricing structure is now available for 963,88 SEK per bottle at pharmacies throughout Sweden AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...

GlobeNewswire, Inc.

If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...

GlobeNewswire, Inc.

The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal thickness showed a substantial and persistent reduction with OCS-01 vs vehicle...

GlobeNewswire, Inc.

— The new pricing structure is made available as of February for 566,13 ISK per day at pharmacies throughout Iceland AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...

GlobeNewswire, Inc.

— The new pricing structure is made available as of February for 26,63 DKK per day at pharmacies throughout Denmark AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...

GlobeNewswire, Inc.

— The new pricing structure is made available as of February for 3.39 EUR per day at pharmacies throughout Finland AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...

GlobeNewswire, Inc.

— The new pricing structure is made available as of February for 32,13 SEK per day at pharmacies throughout Sweden AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...

GlobeNewswire, Inc.

ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology,...

GlobeNewswire, Inc.

Ottawa, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The radiopharmaceutical CDMO market is driven by rising nuclear medicine use, growing outsourcing of radiopharmaceutical development, and demand for compliant, end-to-end manufacturing solutions.

GlobeNewswire, Inc.

Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON underscore the significant...

GlobeNewswire, Inc.

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...

GlobeNewswire, Inc.

Presented new data on CLD-401 at the AACR conference in San Diego, CA, detailing the profound immune changes in the tumor microenvironment induced by CLD-401; IND filing for CLD-401 expected by end of 2026 Presented new data on RedTail at the AACR...

GlobeNewswire, Inc.

ISSAQUAH, Wash., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $23.12 billion for the retail month of July, the four weeks ended August 2, 2026, an increase of...

EIN Presswire

The Business Research Company's Flavored Milk Powder Drinks Market Outlook 2030: Market Size, CAGR, Trends And Forecast Analysis LONDON, GREATER LONDON, UNITED KINGDOM, July 17, 2026 /⁨EINPresswire.com⁩/ -- "The flavored milk powder drinks sector...

GlobeNewswire, Inc.

REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...

GlobeNewswire, Inc.

First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...

GlobeNewswire, Inc.

REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission...

GlobeNewswire, Inc.

Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from DIAMOND Phase 3 trials with OCS-01 eye drops in diabetic macular edema (DME) in Q2...